Rivastigmine Market: analysis and a holistic overview of the market situations in the forecast period.
Rivastigmine Rivastigmine Sandoz is a medication that contains the active ingredient Exelon. It comes in the form of capsules (yellow: 1.5 mg; orange: 3 mg; red: 4.5 mg; red and orange: 6 mg) and an oral solution (2 mg/ml). This medicine is the same as Exelon capsules and oral solution, which is already approved in the European Union (EU). Exelon's manufacturer has agreed to allow Exelon Sandoz to use its scientific data. Rivastigmine Sandoz is used to treat patients with mild to moderately severe Alzheimer's dementia, a progressive brain disorder that affects memory, cognitive ability, and behavior over time. Exelon Sandoz is also used to treat mild to moderately severe dementia in Parkinson's disease patients. Exelon Sandoz should be started and monitored by a doctor who has experience diagnosing and treating Alzheimer's disease or dementia in Parkinson's disease patients. Treatment should begin only if a caregiver is available to monitor the patient's...